Hedge funds are back in investors’ playbook, but not all hedge funds are feeling the love.

According to Hedge Fund Research (HFR), the hedge fund industry saw a net inflow of $12.6 billion for the first quarter of 2025, following 2

In hindsight, it may seem like the first quarter of 2025 was the calm before the storm in comparison to the whipsaws markets have faced since the start of April. However, despite starting the quarter with strong momentum and a fresh record high, equi

Rising Utility: Independent Power Producers in an Electricity Bull Market

The energy landscape, and particularly the market for electricity, is evolving rapidly. Electricity demand and energy infrastructure spending are expected to conti

Despite May's usual reputation for underwhelming performance, U.S. stocks experienced a robust monthly gain. The S&P 500 delivered a total return of 6.3%, marking its biggest gain during the month of May since 1990, and turning positive year

Managed futures funds have faced a difficult 2025, with the HFRX Macro: Systematic Diversified CTA Index down 8.0% through May 23. As one of our preferred liquid alternative implementation choices, a dive into what has been driving this year’s

It has seemingly been a one-way move higher in longer-term interest rates in May, with the 30-year U.S. Treasury yield above 5% again and higher by 0.36% this month alone. Additionally, the 10-year U.S. Treasury yield breached 4.5%, up 0.35% in May a

On May 3, 2025, at the Berkshire Hathaway (BRK) annual shareholders meeting, Chief Executive Officer (CEO) Warren Buffett announced he would be stepping down at the end of the year. Buffett will be succeeded by Greg Abel, the current Vice Chairman of

The equity market’s recovery over the past month has been extraordinary in terms of both speed and scale. A turnaround of such magnitude is highly unusual, and the sudden shift in investor sentiment is among the fastest I have observed in my 25

On May 12, President Donald Trump signed the “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients” executive order aimed at making prescription drugs more affordable for Americans. The premise driving the initiat

In a recent equity strategy publication (ask your LPL advisor for the latest Equity Strategy Insights publication if interested), we identified potential sector winners and losers under various tariff scenarios. During the high tariff, high trade unc